Equity Bancshares, Inc. (EQBK)
NYSEFinancialsBanks - RegionalSnapshot 2026-10-30
NYSEFinancialsBanks - RegionalSnapshot 2026-10-30
Research Workspace
Put EQBK beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Regional Banks is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Earnings per share near $5.05 in 2026: Comparison needs review.
View ThesisRevenue growth is accelerating — up about 33% over the past year.
View GrowthManagement screens weak on capital allocation, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskEQBK’s thesis rests on organic loan growth succeeding through post-merger integration. Recent financial performance is weak, though Q3 FY2026 earnings beat consensus. EPS was $1.40 against $1.31 consensus, and Q2 revenue grew 48.3% year over year. EQBK trades at 1.2× P/B versus a 1.2× peer median. The price reflects less growth than our forecast. The specific pressure is execution: management is unsteady, and Q3 results disappointed on operating income and efficiency. Our model puts the next-quarter miss probability near 21%. The thesis is on watch; peer multiples imply a price about 6% above where it trades. This read is provisional.
Trailing returns as of 2026-10-30. EQBK is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 8 analysts currently covering EQBK (as of Oct 2026).
Based on 3 Wall Street analysts offering 12-month price targets for EQBK in the last 4 months.
Continue this research
Compare EQBK with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| EQBK Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 10 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Regional Banks — fair value, gap to price, and forward P/E.
Compare the value case
Put EQBK next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Execute organic growth and integration post-Frontier merger
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $48.68
The last 12 months of price, then the range of analyst 12-month targets from today’s $48.68.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Specific 2027 organic loan growth target supports post-merger growth and integration objectives.

Advances: Execute organic growth and integration post-Frontier merger
EPS beat and loan growth support organic growth, though the headline alone gives limited detail.

Threatens: Maintain positive operating income and improve efficiency
Q3 results disappointment affects operating income and efficiency.

Advances: Complete merger with Lincoln Bancorp in Q4 2026
Merger agreement supports growth objective and timeline.

Advances: Complete merger with Frontier Holdings LLC
Acquisition supports growth objective post-Frontier merger.
